All engineering research in ATP-Bio is aimed at eliminating or mitigating the three enemies of biopreservation: ice formation, cryoprotective agent (CPA) toxicity, and slow and/or non-uniform rewarming.
We aim to develop new CPAs and CPA delivery, uptake, and removal systems to reduce or eliminate CPA toxicity. This will involve engineering at the molecular, genetic/cellular, and tissue/organ levels.
We aim to mitigate or eliminate ice formation during cooling of biological systems down to -140°C.
We aim to eliminate spontaneous ice formation and thermal cracking that occurs when cryopreserved biological systems are warmed.
Each of our testbeds connects to a distinct market segment. We aim to produce biopreservation technologies that will accelerate the growth of each of these market segments via new products and vastly improved storage and distribution of products.
